NCT06434350View on ClinicalTrials.gov

Enfortumab Vedotin With Radiation for Locally Advanced Bladder Cancer (CONSOLIDATE)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

October 10, 2024

Primary Completion Date

September 24, 2027

Study Completion Date

September 24, 2027

Conditions
Advanced Bladder Cancer
Interventions
DRUG

Enfortumab Vedotin

Given by IV

RADIATION

Radiation Therapy

Given by Radiation Therapy

Trial Locations (1)

77030

RECRUITING

MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER